Search Results 2391-2400 of 40547 for Two-phase

  1. Mayo Clinic Q and A: Heart disease and kidney disease - what's the connection?

    She was feeling better for a bit, but became ill again and was told she has an acute kidney injury. Are the two conditions somehow related? Is she at higher ...

  2. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in combination ...

  4. A Multicenter Study To Evaluate The Efficacy And Safety Of Cinryze® For The Treatment Of Acute Antibody-mediated Rejection In Patients With Kidney Transplant - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease - Mayo Clinic

    This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of ...

  6. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. Cynthia Weiss Archives - Mayo Clinic News Network

    ... Two years later, the cancer came back. Technology ... nothing. Six months later, it happened again. Two ... thanks to a phase I clinical trial"; "Dear Mayo ...

  8. Novel Study Interventions and Combinations in Participants with Colorectal Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...